du-21220 has been researched along with Cardiomyopathy, Hypertrophic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, OF; Karademir, S; Ocal, B; Oguz, D | 1 |
| Brodsky, N; Hurt, H; Nuchpuckdee, P; Porat, R | 1 |
2 other study(ies) available for du-21220 and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Asymmetric septal hypertrophy in an infant exposed to ritodrine in utero.
Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Hypertrophic; Female; Humans; Infant, Newborn; Male; Maternal Exposure; Ritodrine | 2000 |
Ventricular septal thickness and cardiac function in neonates after in utero ritodrine exposure.
Topics: Cardiomyopathy, Hypertrophic; Echocardiography; Female; Glycogen; Heart Septum; Humans; Hypertension, Pulmonary; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Prenatal Exposure Delayed Effects; Ritodrine; Tachycardia | 1986 |